The National Marrow Donor Program (NMDP)
Showing 1 - 25 of >10,000
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Samples and Data for National Marrow Donor Program Repository
Recruiting
- Bone Marrow Transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 1, 2022
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
AML Patients After Stem Cell Transplant to Understand Relapse
Recruiting
- Acute Myeloid Leukemia in Remission
- Prospective determination of the clinical utility of measurable residual disease (MRD) testing
-
Duarte, California
- +3 more
Dec 7, 2022
Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,
Recruiting
- Primary T-cell Immunodeficiency Disorders
- +4 more
- Immunosuppression Only Conditioning -Closed with amendment L
- +4 more
-
Bethesda, Maryland
- +1 more
Jul 26, 2022
Allogeneic Hematopoietic Cell Transplantation in Medicare
Recruiting
- Multiple Myeloma
- Allogeneic Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Biology of Long-Term Late Effects Following Hematopoietic Cell
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
-
Scottsdale, Arizona
- +31 more
Mar 8, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Healthy Trial in Camden (Emotional Appeal, Rational Appeal)
Recruiting
- Healthy
- Emotional Appeal
- Rational Appeal
-
Camden, New JerseyRutgers University Camden
Oct 28, 2022
Improved Methods of Cell Selection for Bone Marrow Transplant
Recruiting
- Graft-Versus-Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Venetoclax
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Mar 22, 2023
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Blood Donation Among Secondary School Students in Malawi Trial (Club 25)
Not yet recruiting
- Blood Donation Among Secondary School Students in Malawi
- Club 25
- (no location specified)
Nov 15, 2023
Leukemia, MDS Trial (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +7 more
- (no location specified)
Feb 17, 2022
Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting
- Myelodysplastic Syndrome (MDS)
- +3 more
- Cord Blood Transplant
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 22, 2021
Hematopoietic and Lymphoid Cell Tumor Trial in United States (Best Practice and Internet site with links to existing resources,
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Best Practice and Internet site with links to existing resources
- +2 more
-
Tampa, Florida
- +14 more
Dec 5, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Kidney Diseases Trial in Birmingham (Living Donor Navigator Program)
Not yet recruiting
- Kidney Diseases
- Living Donor Navigator Program
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 18, 2022